Physician profile
David D Berg
NPI 1255625471
$75,977.54
in general payments reported to CMS, 2019-2025
12 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,384 · 2022: $2,014 · 2023: $24K · 2024: $15K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $30K · Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,281.25 |
| Travel and Lodging | $30,187.84 |
| Food and Beverage | $1,110.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Ab | $21,932.91 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $19,301.37 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16,378.50 | 2024-2025 | Breztri |
| Astrazeneca Uk Limited | $12,908.21 | 2023-2025 | |
| Pfizer INC. | $3,500.00 | 2025 | |
| Beckman Coulter, INC. | $1,575.00 | 2024 | |
| Getinge USA Sales, LLC | $194.28 | 2023 | Cardiohelp |
| Kestra Medical Technology Services, INC. | $100.00 | 2023 | Assure Wcd |
| Ethicon US, LLC | $39.47 | 2024 | Stratafix, Monocryl |
| Angiodynamics, INC. | $17.39 | 2025 | Alphavac |
| Medtronic, INC. | $15.49 | 2024 | Invos |
| Davol INC. | $14.92 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.